Paushak Ltd. (BSE: 532742) is a Vadodara, Gujarat-based company in the Custom Synthesis and Specialty CDMO industry. With a market capitalisation of ₹1,487 Cr, it ranks #1,389 by market cap among the 6,197 Indian listed companies on FinBizNet, and #6 of 13 in Custom Synthesis and Specialty CDMO. At ₹600.00 (as of 16 Nov 2026), the share price is 32.0% below its 52-week high of ₹881.95 and 75.2% above its 52-week low of ₹342.50.
| Current Price | ₹600.00 |
|---|---|
| Market Cap | ₹1,487 Cr |
| BSE Code | 532742 |
| Sector | Materials > Chemicals > Speciality Chemicals |
| Sub-Industry | Specialty Chemicals > Custom Synthesis and Specialty CDMO |
| P/E Ratio | 38.1 |
| Return on Equity | 8.22% |
| Return on Assets | 4.01% |
| 52-Week Range | ₹342.50 – ₹881.95 |
| 3-Month Price Change | -19.7% |
| Beta (1Y) | 0.73 |
| Dividend Yield | 0.41% |
| Headquarters | Vadodara, Gujarat |
| Website | www.paushak.com |
| Revenue | ₹89 Cr |
|---|---|
| Net Profit | ₹14 Cr |
| Net Margin | 15.1% |
| EPS (Basic) | ₹5.48 |
| Basis | standalone |
Figures in ₹ crore, parsed from the company's exchange filing (XBRL).
Paushak Ltd. reported revenue of ₹89 Cr in Q2 FY27, up 6.9% from ₹84 Cr in Q1 FY27. It posted a net profit of ₹14 Cr for the quarter, against a net profit of ₹15 Cr in Q1 FY27 (down 10.5%). Across the 4 quarters from Q3 FY26 to Q2 FY27, quarterly revenue ranged from ₹49 Cr (Q3 FY26) to ₹89 Cr (Q2 FY27). The company was profitable in each of these 4 quarters.
| Quarter | Revenue | Net Profit | Net Margin |
|---|---|---|---|
| Q2 FY27 | ₹89 Cr | ₹14 Cr | 15.1% |
| Q1 FY27 | ₹84 Cr | ₹15 Cr | 18.1% |
| Q4 FY26 | ₹55 Cr | ₹13 Cr | 22.7% |
| Q3 FY26 | ₹49 Cr | ₹6 Cr | 12.6% |
Standalone figures (₹ crore, XBRL filings).
Promoters held 67.28% of Paushak Ltd.'s shares as of Sept 2026, unchanged from Nov 2025. Delivery averaged 49.4% of traded volume across 16 NSE sessions (22 Oct 2026 – 13 Nov 2026).
Paushak Limited manufactures and sells specialty chemicals and intermediates in India and internationally. It offers chloroformates, isocyanates, chlorides, carbonate/carbamate, and custom synthesis and CDMO. The company servers its products to pharmaceuticals, agrochemicals, and performance and custom synthesis industries. Paushak Limited was founded in 1968 and is based in Vadodara, India.
1. Speciality Chemicals-This segment develops, manufactures, and sells phosgene based specialty chemicals and intermediates.
1. Speciality Chemicals-100%
| Company | Market Cap | P/E | ROE | Latest Qtr Revenue | 1Y Change |
|---|---|---|---|---|---|
| Anupam Rasayan India Ltd | ₹13,570 Cr | 79.6 | 5.76% | ₹806 Cr | +20.1% |
| Neogen Chemicals Limited (Neogen) | ₹8,322 Cr | 259.2 | 3.58% | ₹296 Cr | +93.4% |
| Prasol Chemicals Limited | ₹4,681 Cr | 58.1 | — | ₹413 Cr | — |
| Laxmi Organic Industries Ltd | ₹4,574 Cr | 57.2 | 4.08% | ₹1,083 Cr | -18.9% |
| Tatva Chintan Pharma Chem Ltd | ₹3,871 Cr | 92.5 | 5.53% | ₹217 Cr | +12.2% |
| Paushak Ltd. | ₹1,487 Cr | 38.1 | 8.22% | ₹89 Cr | — |
| Sunshield Chemicals Ltd. | ₹833 Cr | 25.2 | 17.02% | — | +12.6% |
| Chemcon Speciality Chemicals Limited | ₹733 Cr | 31.8 | 4.80% | ₹65 Cr | -12.8% |
| Resonance Specialties Ltd. | ₹327 Cr | 31.5 | 15.15% | — | +203.4% |
Listed by market capitalisation. Ratios are shown for context only.
Paushak Ltd. is trading at ₹600.00, with a market capitalisation of ₹1,487 Cr.
Paushak Ltd. operates in the Materials > Chemicals > Speciality Chemicals space (Specialty Chemicals > Custom Synthesis and Specialty CDMO).
Paushak Ltd. has a P/E of 38.1 and a return on equity of 8.22%.
Paushak Ltd. is listed on the BSE under the scrip code 532742.
In Q2 FY27, Paushak Ltd. reported revenue of ₹89 Cr and net profit of ₹14 Cr, with basic EPS of ₹5.48 (standalone, parsed from the company's exchange filing).
Promoters held 67.28% of Paushak Ltd.'s shares as of Sept 2026, unchanged from Nov 2025.
Data as of 16 Nov 2026. Descriptive market data only — not investment advice.